LBX Pharmacy Chain Joint Stock Company (SHA:603883)
China flag China · Delayed Price · Currency is CNY
14.91
0.00 (0.00%)
Nov 18, 2026, 3:00 PM CST

SHA:603883 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
22,70022,12022,21322,28820,05515,579
Other Revenue
116.57116.57144.48149.26120.29117.11
22,81622,23722,35822,43720,17615,696
Revenue Growth
2.80%-0.54%-0.36%11.21%28.54%12.38%
Cost of Revenue
15,51115,06414,94615,15713,75110,659
Gross Profit
7,3067,1737,4127,2806,4255,037
Selling, General & Admin
5,9665,9876,2055,7535,0053,990
Research & Development
21.7351.072.012.512.23-
Other Operating Expenses
42.1925.0933.6846.2138.5114.95
Operating Expenses
6,0546,0826,2475,8115,0534,010
Operating Income
1,2521,0911,1651,4691,3711,027
Interest Expense
-110.26-130.27-178.25-185.6-232.14-192.13
Interest & Investment Income
13.3714.2722.8393.8751.3537.14
Currency Exchange Gain (Loss)
---1.25-5.22-16.914.8
Other Non Operating Income (Expenses)
-27.65-17.43-13.65-14.61-13.4-14.44
EBT Excluding Unusual Items
1,128957.59994.51,3571,160861.9
Impairment of Goodwill
-150.34-150.34-107.54---
Gain (Loss) on Sale of Investments
-1.5---1.55.7710.47
Gain (Loss) on Sale of Assets
-3.95-3.54-4.535.511.444.66
Asset Writedown
-86.46-88.26----
Other Unusual Items
41.5140.7233.5446.6940.2184.95
Pretax Income
927.08756.17915.971,4081,208961.99
Income Tax Expense
282.18215.72230.85284.27231.37175.26
Earnings From Continuing Operations
644.89540.45685.121,124976.24786.73
Minority Interest in Earnings
-174-158.6-166.05-194.54-191.28-117.49
Net Income
470.9381.85519.06929.02784.96669.24
Net Income to Common
470.9381.85519.06929.02784.96669.24
Net Income Growth
12.77%-26.43%-44.13%18.35%17.29%7.75%
Shares Outstanding (Basic)
769764763755750707
Shares Outstanding (Diluted)
769764763755750707
Shares Change
1.17%0.05%1.06%0.67%6.08%2.42%
EPS (Basic)
0.610.500.681.231.050.95
EPS (Diluted)
0.610.500.681.231.050.95
EPS Growth
11.47%-26.47%-44.71%17.57%10.57%5.20%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
3,0252,8891,5192,1092,0061,820
Free Cash Flow Per Share
3.933.781.992.792.672.57
Dividend Per Share
0.5700.4100.4110.5080.3850.296
Dividend Growth
159.09%-0.17%-19.11%32.01%30.02%42.83%
Gross Margin
32.02%32.26%33.15%32.45%31.84%32.09%
Operating Margin
5.49%4.91%5.21%6.55%6.80%6.54%
Profit Margin
2.06%1.72%2.32%4.14%3.89%4.26%
Free Cash Flow Margin
13.26%12.99%6.79%9.40%9.94%11.59%
EBITDA
1,3751,2631,4031,6621,5331,162
EBITDA Margin
6.02%5.68%6.28%7.41%7.60%7.41%
D&A For EBITDA
122.16171.99238.43193.69161.87135.67
EBIT
1,2521,0911,1651,4691,3711,027
EBIT Margin
5.49%4.91%5.21%6.55%6.80%6.54%
Effective Tax Rate
30.44%28.53%25.20%20.19%19.16%18.22%
Revenue as Reported
22,81622,23722,35822,43720,17615,696
Advertising Expenses
-101.47115.57117.9994.5109.84